81/163US=4 / Câncer
Silla L, Bittencourt R. Mieloma múltiplo. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 716-22. ISBN 85-3631168-5.

MIELOMA MULTIPLO. DIAGNOSTICO; MIELOMA MULTIPLO. PATOLOGIA; MIELOMA MULTIPLO. ESTADIAMENTO; MIELOMA MULTIPLO. FATORES DE RISCO; MIELOMA MULTIPLO. PROGNOSTICO; MIELOMA MULTIPLO. TRATAMENTO


82/163US=4 / Câncer
Vinholes J. Bisfosfonatos em metástases ósseas. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 897-903. ISBN 85-3631168-5.

METASTASES OSSEAS; BISFOSFONATOS; MIELOMA MULTIPLO; CANCER DE MAMA; CANCER DE PROSTATA


83/163US=64 / Câncer
Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR


84/163US=64 / Câncer
Langston AA, Francis D. Epidemiology of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 9-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

EPIDEMIOLOGIA; MIELOMA MULTIPLO


85/163US=64 / Câncer
Chng WJ, Bergsagel PL. Biology-based classification and staging of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 41-56. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BIOLOGIA BASEADA EM MIELOMA MULTIPLO; ESTADIAMENTO DO MIELOMA MULTIPLO


86/163US=64 / Câncer
Braggio E, Sebag M, Fonseca R. Cytogenetic abnormalities in multiple myeloma: the importance of FISH and cytogenetics. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 57-76. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

ANOMALIAS CITOGENETICAS EM MIELOMA MULTIPLO


87/163US=64 / Câncer
Harousseau JL. Role of autologous stem cell transplantation in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 79-90. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRANSPLANTE AUTOLOGO DE CELULAS-TRONCO NO MIELOMA MULTIPLO; TERAPIA DE ALTA DOSE; HDT; AUTOLOGO TRANSPLANTE DE CELULAS ESTAMINAIS


88/163US=64 / Câncer
Kaufman JL, Mihelic R, Lonial S. Maintenance therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 91-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPIA DE MANUTENCAO NO MIELOMA MULTIPLO


89/163US=64 / Câncer
Ailawadhi S, Chanan-Khan A. Current role of anthracyclines in the treatment of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 113-21. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRATAMENTO DO MIELOMA MULTIPLO. ANTRACICLINAS; ANTRACICLINAS


90/163US=64 / Câncer
Wang F, Waller EK. Allogeneic transplantation for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 125-42. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TRANSPLANTE ALOGENICO DE MIELOMA MULTIPLO; CLONAL DE CELULAS B; IMUNOTERAPIA ANTI MIELOMA


91/163US=64 / Câncer
Munshi NC, Tai YT. Antibody and other immune-based therapies for myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

ANTICORPOS; IMUNO-TERAPIAS BASEADAS PARA MIELOMA; ANTICORPOS CONTRA O TUMOR


92/163US=64 / Câncer
Badros A. Thalidomide in patients with relapsed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 205-27. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TALIDOMIDA EM PACIENTES MIELOMA MULTIPLO; TALIDOMIDA E MIELOMA


93/163US=64 / Câncer
Buadi FK, Rajkumar SV. Thalidomide: induction therapy. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 229-37. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TALIDOMIDA; TERAPIA DE INDUCAO; MIELOMA MULTIPLO; CLONAL DE CELULAS ESTAMINAIS


94/163US=64 / Câncer
Richardson PG, Mitsiades CS, Schlossman R, Hideshima T, Ghobrial I, Munshi NC, Anderson KC. The role of bortezomib in the treatment of relapsed and refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 239-52. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BORTEZOMIB; MIELOMA MULTIPLO REFRACTARIO. TRATAMENTO


95/163US=64 / Câncer
San MFJ, Mateos MV. Bortezomib as induction therapy in patients with multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 253-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

BORTEZOMIB; PACIENTES COM MIELOMA MULTIPLO. TERAPIA DE INDUCAO


96/163US=64 / Câncer
Yhomas SK, Richards TA, Weber DM. Lenalidomide in relapsed or refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 265-77. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

LENALIDOMIDA EM RECIDIVA; MIELOMA MULTIPLO REFRACTARIO; ESTEROIDES; ANTRACICLINAS


97/163US=64 / Câncer
Kumar S. Lenalidomide for initial therapy of newly diagnosed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 279-88. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

LENALIDOMIDA. TERAPIA COM MIELOMA MULTIPLO; MALIGNIDADE HEMATOLOGICA. LINFOMA NAO-HODGKIN


98/163US=64 / Câncer
Mitsiades CS, Hideshima T, Munshi NC, Richardson PG, Anderson KC. The role of heat shock protein 90 as a therapeutic target for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 291-308. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPEUTICO PARA O MIELOMA MULTIPLO; CHAPERONE MOLECULAR UBIQUAMENTE


99/163US=64 / Câncer
Harvey RD, Silberman J, Lonmial S. The PI3 kinase/akt pathway as a therapeutic target in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 309-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

PI3 QUINASE; AKT; TERAPEUTICO NO MIELOMA MULTIPLO; MIELOMA MULTIPLO. TERAPIAS


100/163US=64 / Câncer
Frost P, Lichtenstein A. The mammalian target of rapamycin and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 323-30. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

RAPAMICINA EM MAMIFEROS; MIELOMA MULTIPLO; CELULAS EUCARIOTICAS; IMUNO-HISTOQUIMICA


Primeira | Anterior | Próxima | Última